arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ
$0.61 ▼ -0.05 (-7.00%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
66 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC -18.0% ↗
FCF / Share None
Trailing P/E —
Price / Book 0.5x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-1.51M
↓ -22.6% —
Operating Margin Operating profit as % of sales
-314.9%
↑ +33.8% —
FCF / Share Free cash flow per share
$-0.24
↓ -62905.7% —
Long-Term Debt Long-term obligations
$342.45K
↓ -48.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
11
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 66 quarters